Principal Financial Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.08M | Buy |
|
|||||
|
2025
Q2 | $113K | Sell |
|
|||||
|
2025
Q1 | $191K | Sell |
|
|||||
|
2024
Q4 | $237K | Sell |
|
|||||
|
2024
Q3 | $291K | Sell |
|
|||||
|
2024
Q2 | $2.39M | Buy |
|
|||||
|
2024
Q1 | $2.8M | Buy |
|
|||||
|
2023
Q4 | $2.34M | Buy |
|
|||||
|
2023
Q3 | $1.67M | Buy |
|
|||||
|
2023
Q2 | $1.44M | Sell |
|
|||||
|
2023
Q1 | $1.27M | Sell |
|
|||||
|
2022
Q4 | $1.57M | Buy |
|
|||||
|
2022
Q3 | $753K | Sell |
|
|||||
|
2022
Q2 | $796K | Sell |
|
|||||
|
2022
Q1 | $739K | Buy |
|
|||||
|
2021
Q4 | $886K | Sell |
|
|||||
|
2021
Q3 | $1.03M | Buy |
|
|||||
|
2021
Q2 | $985K | Sell |
|
|||||
|
2021
Q1 | $1.12M | Sell |
|
|||||
|
2020
Q4 | $2.75M | Buy |
|
|||||
|
2020
Q3 | $1.3M | Sell |
|
|||||
|
2020
Q2 | $1.47M | Buy |
|
|||||
|
2020
Q1 | $663K | Buy |
|
|||||
|
2019
Q4 | $688K | Buy |
|
|||||
|
2019
Q3 | $561K | Buy |
|
|||||
|
2019
Q2 | $791K | Buy |
|
|||||
|
2019
Q1 | $738K | Buy |
|
|||||
|
2018
Q4 | $502K | Sell |
|
|||||
|
2018
Q3 | $1.93M | Buy |
|
|||||
|
2018
Q2 | $2.32M | Buy |
|
|||||
|
2018
Q1 | $2.02M | Buy |
|
|||||
|
2017
Q4 | $1.81M | Buy |
|
|||||
|
2017
Q3 | $336K | Sell |
|
|||||
|
2017
Q2 | $265K | Sell |
|
|||||
|
2017
Q1 | $192K | Buy |
|
|||||
|
2016
Q4 | $131K | Buy |
|
|||||
|
2016
Q3 | $168K | Buy |
|
|||||
|
2016
Q2 | $122K | Buy |
|
|||||
|
2016
Q1 | $171K | Buy |
|
|||||
|
2015
Q4 | $195K | Buy |
|
|||||
|
2015
Q3 | $274K | Buy |
|
|||||
|
2015
Q2 | $206K | Buy |
|